DOSE CYTOMEGALOVIRUS INFECTION PREDICT A LOWER RISK OF DISEASE RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION? A META-ANALYSIS OF OBSERVATIONAL STUDIES
第一作者机构：[1]Department of Hematology, The First Affi liated Hospital of Chongqing Medical University, Chongqing, China
通讯作者：
推荐引用方式(GB/T 7714)：
Luo X. -H.,Zhang Y. -L.,Liu L..DOSE CYTOMEGALOVIRUS INFECTION PREDICT A LOWER RISK OF DISEASE RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION? A META-ANALYSIS OF OBSERVATIONAL STUDIES[J].BONE MARROW TRANSPLANTATION.2014,49:S322-S322.
APA：
Luo, X. -H.,Zhang, Y. -L.&Liu, L..(2014).DOSE CYTOMEGALOVIRUS INFECTION PREDICT A LOWER RISK OF DISEASE RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION? A META-ANALYSIS OF OBSERVATIONAL STUDIES.BONE MARROW TRANSPLANTATION,49,
MLA：
Luo, X. -H.,et al."DOSE CYTOMEGALOVIRUS INFECTION PREDICT A LOWER RISK OF DISEASE RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION? A META-ANALYSIS OF OBSERVATIONAL STUDIES".BONE MARROW TRANSPLANTATION 49.(2014):S322-S322
